Recent changes
Virginia Pharmacy Law and Regulatory Updates
The Virginia Board of Pharmacy presented updates on recent legislative and regulatory changes affecting pharmacy practice. Key changes include expanded educational standards for pharmacy technicians and new provisions for collaborative practice agreements allowing pharmacists to prescribe certain controlled substances.
Virginia Pharmacy Technician Registration Requirements Updated
The Virginia Board of Pharmacy is implementing new registration requirements for pharmacy technicians, effective July 1, 2025. Individuals will need to complete an accredited training program or equivalent and pass a national certification exam to be registered.
Massachusetts: 90-day Supply for Certain Schedule II/III Prescriptions
The Massachusetts Board of Registration in Pharmacy updated its policy to allow a 90-day supply for certain Schedule II and III prescriptions, including those for opioid use disorder treatment, non-opioid stimulants, testosterone, and implantable infusion pumps. Other Schedule II and III medications remain limited to a 30-day supply.
MA Board Adopts Rapid Microbial Methods for Sterility Testing
The Massachusetts Board of Registration in Pharmacy has adopted a new policy allowing the use of Rapid Microbial Methods (RMMs) as an alternative for sterility release testing of compounded sterile preparations (CSPs). This policy outlines requirements for licensed sterile compounding pharmacies to ensure public safety when using these advanced technologies.
Rapid Microbial Methods Sterility Testing Guidance
The Massachusetts Department of Public Health has issued guidance on the use of Rapid Microbial Methods (RMMs) for sterility testing. This document outlines acceptable approaches and considerations for implementing RMMs in pharmaceutical and medical device manufacturing.
Massachusetts Pharmacy Practice Definitions
The Massachusetts Board of Registration in Pharmacy has issued a document defining key terms related to pharmacy practice. This guidance aims to clarify terminology for pharmacists and related entities operating within the state.
Pharmacy Policy: Definitions for Automated Dispensing, Compounding, and Events
The Massachusetts Board of Registration in Pharmacy has adopted Policy 2025-02, defining key terms related to automated dispensing devices, automated pharmacy systems, pharmacy processing automation, quality-related events, and serious adverse drug events. These definitions clarify regulatory expectations for pharmacies operating in the state.
California Board of Pharmacy News Roundup - August 2025
The California Board of Pharmacy issued a news roundup for August 2025, providing updates on Rite Aid closures, emergency refills, medication error reporting requirements effective September 1, 2025, and a new online portal for drug theft/loss reporting. A new Pharmacist-in-Charge training webinar is also available.
California Board of Pharmacy: Vaccine Administration Update
The California Board of Pharmacy issued a news roundup detailing changes to pharmacist authority regarding vaccine administration, effective January 1, 2026, due to Assembly Bill 1503. The update encourages pharmacists to transition to a standard of care practice model for immunizations for patients three years and older.
California Board of Pharmacy December Update: Standard of Care, Vaccines, CAMER
The California Board of Pharmacy's December 2025 update announces the transition of certain pharmacist-provided patient care services, including vaccine administration, to a standard of care model effective January 1, 2026, per AB 1503. It also reminds schools about standing orders for albuterol and epinephrine and mandates reporting medication errors to the CAMER system for events on or after September 1, 2025.
Get daily alerts for pharma & life sciences
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
691 changes in last 7 days
Latest high priority updates
140 official sources tracked
Frequently asked questions
What does this feed cover?
FDA warning letters, novel drug approvals, drug shortage notices, ICH guideline updates, USP notices, EMA news, DEA scheduling decisions, and TGA/WHO standards.
Who is this for?
Regulatory affairs professionals, pharmacovigilance teams, and medical affairs groups at pharma companies and CROs who need to track FDA and EMA actions.
How often is this updated?
GovPing checks source pages multiple times daily. FDA warning letters and drug approvals typically appear within hours of publication.
Does this cover EMA and international regulators?
Yes. We monitor the EMA, ICH, WHO, TGA (Australia), and other international health authorities alongside FDA.
How is this different from AgencyIQ?
AgencyIQ is a full FDA intelligence platform. GovPing is a free feed of the FDA, EMA, and ICH source pages where warning letters, approvals, drug shortages, and guidance are first published - AI-summarized with attention-level ratings on every change.
Is GovPing free?
Yes. GovPing is free, and always will be. We believe government regulatory data should be accessible to everyone. For custom monitoring of pages we don't cover yet, Changeflow starts at $99/mo.
Need to monitor something else?
GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.
Get Pharma & Life Sciences alerts
Daily digest of pharma & life sciences regulatory changes. AI-summarized, no noise.
Free. Unsubscribe anytime.